Trials / Completed
CompletedNCT05552378
Multi-Gyn FloraFem Study for Treatment of Vulvo Vaginal Candidiasis Symptoms
A Single Arm Stuidy to Confirm Safety and Efficacy of Multi-Gyn FloraFem Study for Treatment of Vulvo Vaginal Candidiasis Symptoms
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Karo Pharma AB · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Women diagnosed with Vulvovaginal Candidiasis by the health care professional will be enrolled in the study. All participants should fulfil inclusion and exclusion criteria. The study product will be used for 5 days, once a day. The doctor will evaluate the patients before and at the end of the treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Multi-Gyn FloraFem | Vaginal gel packed in 5 single use plastic tubes. |
Timeline
- Start date
- 2023-02-20
- Primary completion
- 2023-03-30
- Completion
- 2023-04-05
- First posted
- 2022-09-23
- Last updated
- 2023-06-01
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT05552378. Inclusion in this directory is not an endorsement.